Work

Efficacy of nivolumab and ipilimumab (Nivo + Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.9554

Authors: Alexander Noor Shoushtari, Pedram Navid-Azarbaijani, Claire Frances Friedman, Katherine Panageas, Michael Andrew Postow, Margaret K. Callahan, Parisa Momtaz, Shonnette C. Campbell, Yelena Shames, Nana A. Prempeh-Keteku, Kasiemobi Nwaedozie, Jedd D. Wolchok, Paul B. Chapman

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890791585

Cites:

Cited by: 13

Related to: 10